India to Hungary: Fenofibrate Export Trade Route
India has recorded 24 verified shipments of Fenofibrate exported to Hungary, representing a combined trade value of $4.2M USD. This corridor is served by 3 active Indian exporters, with an average shipment value of $174.4K USD. The leading Indian exporter is ABBOTT HEALTHCARE PRIVATE LIMITED, which accounts for 100% of total export value with 18 shipments worth $4.2M USD. On the buying side, MYLAN HUNGARY KFT is the largest importer in Hungary with $4.2M USD in purchases. The top 3 suppliers — ABBOTT HEALTHCARE PRIVATE LIMITED, MYLAN LABORATORIES LIMITED, LAUREL PHARMA LABS — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.

Route Intelligence Overview
The India to Hungary Fenofibrate corridor is one of India's established pharmaceutical export routes, with 24 shipments documented worth a combined $4.2M USD. The route is dominated by ABBOTT HEALTHCARE PRIVATE LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's fenofibrate manufacturing sector.
Across 3 active suppliers, the average shipment value stands at $174.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with fenofibrate's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 22 days port-to-port. The route has recorded an annual growth rate of 21.1%, placing it at rank #17 among India's top fenofibrate export destinations globally.
On the import side, key buyers of Indian fenofibrate in Hungary include MYLAN HUNGARY KFT, ANNA ASZALOS MYLAN HUNGARY KFT H, MYLAN HUNGARY KFT KOMAROM PLANT MYLAN U. MYLAN HUNGARY KFT is the single largest importer with 18 shipments valued at $4.2M USD.
Route Characteristics
- Average transit22 days
- Peak seasonQ2
- Primary modeSea freight
- Top portCHAWAPAYAL ICD (INCPR6)
Market Position
- Global rank#17
- Annual growth+21.1%
- Demand growth+19.8%
- Regulatory ease84/100
Top 10 Indian Fenofibrate Exporters to Hungary
Showing top 10 of 3 Indian suppliers exporting Fenofibrate to Hungary, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ABBOTT HEALTHCARE PRIVATE LIMITED Avg $232.3K per shipment | 18 | $4.2M | 99.9% |
| 2 | MYLAN LABORATORIES LIMITED Avg $861 per shipment | 5 | $4.3K | 0.1% |
| 3 | LAUREL PHARMA LABS Avg $750 per shipment | 1 | $750 | 0.0% |
This table shows the top 10 of 3 Indian companies exporting fenofibrate to Hungary, ranked by total trade value. The listed exporters are: ABBOTT HEALTHCARE PRIVATE LIMITED, MYLAN LABORATORIES LIMITED, LAUREL PHARMA LABS. ABBOTT HEALTHCARE PRIVATE LIMITED is the dominant supplier with 18 shipments worth $4.2M USD, giving it a 100% market share.
Top 10 Fenofibrate Importers in Hungary
Showing top 10 of 3 known buyers in Hungary receiving Fenofibrate shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian fenofibrate in Hungary include MYLAN HUNGARY KFT, ANNA ASZALOS MYLAN HUNGARY KFT H, MYLAN HUNGARY KFT KOMAROM PLANT MYLAN U. The largest importer is MYLAN HUNGARY KFT, accounting for $4.2M USD across 18 shipments — representing 100% of all fenofibrate imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MYLAN HUNGARY KFT | 18 | $4.2M | 99.9% |
| 2 | ANNA ASZALOS MYLAN HUNGARY KFT H | 5 | $4.3K | 0.1% |
| 3 | MYLAN HUNGARY KFT KOMAROM PLANT MYLAN U | 1 | $750 | 0.0% |
Top 10 Fenofibrate Formulations Imported by Hungary
Showing top 10 of 24 product formulations shipped on the India to Hungary Fenofibrate route, ranked by trade value
Hungary imports a wide range of fenofibrate formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — FENOFIBRATE TAB 145MG B.NO.FFC24027 MFGDT 03.24 EXP 03.25 B.NO-FFC24028,FFC24029,FFC24030,FFC24031MFG 03.24EXP 03.25 — accounts for $261.7K USD across 1 shipments. There are 24 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | FENOFIBRATE TAB 145MG B.NO.FFC24027 MFGDT 03.24 EXP 03.25 B.NO-FFC24028,FFC24029,FFC24030,FFC24031MFG 03.24EXP 03.25 | 1 | $261.7K | 6.3% |
| 2 | FENOFIBRATE TAB 145MG BATCH NO. FFC23088, FFC23089,FFC23090,FFC23091,FFC23092 MFG DT.12.2023 EXP DT.12.2024KGS | 1 | $260.2K | 6.2% |
| 3 | FENOFIBRATE TAB 145MG B.NO-BATCH NO.FFC24046,FFC24047,FFC24048,FFC24049,FFC24050 MFG DT-05.24EXP DT-05.25 | 1 | $259.4K | 6.2% |
| 4 | FENOFIBRATE TAB 145MG B.NO-BATCH NO.FFC24041FFC24042MFG-04.24EXP04.25FFC24043FFC24044FFC24045MFG-05.24EXP-05.25 | 1 | $259.1K | 6.2% |
| 5 | FENOFIBRATE TABLETS 145MG B NO-FFC25006TO FFC25010 MFG DT. JAN-2025 & EXP. DT JAN-2026 | 1 | $240.2K | 5.7% |
| 6 | FENOFIBRATE TABLETS 145MG B NO-FFC25011,FFC25013 TO FFC25016 MFG DT. JAN-2025 &EXP. DT JAN-2026 | 1 | $238.9K | 5.7% |
| 7 | FENOFIBRATE TAB 145MG BNO.FFC25001 TO FFC25005 MFG JAN/2025 EXP JAN/2026 | 1 | $238.1K | 5.7% |
| 8 | FENOFIBRATE TAB 145MG BNO.FFC24113 TO FFC24115 MFG NOV/2024 EXP NOV/2025 FFC24126 & FFC24127 MFG DEC/2024 EXP DEC/2025 | 1 | $237.2K | 5.7% |
| 9 | FENOFIBRATE TABLETS 145MG B NO-FFC25012,FFC25017 TO FFC25020 MFG DT. JAN-2025 &EXP. DT JAN-2026 | 1 | $236.9K | 5.7% |
| 10 | FENOFIBRATE TABLETS 145MG B NO-FFC25021TO FFC25025 MFG DT. FEB-2025 & EXP. DT FEB-2026 | 1 | $236.8K | 5.7% |
Showing top 10 of 24 Fenofibrate formulations imported by Hungary on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 80%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
CHAWAPAYAL ICD (INCPR6) handles the highest volume with 8 shipments. Transit time averages 22 days by sea.
Market Dynamics
India's fenofibrate exports to Hungary are driven primarily by a handful of large-scale manufacturers. ABBOTT HEALTHCARE PRIVATE LIMITED with 18 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in Hungary benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — ABBOTT HEALTHCARE PRIVATE LIMITED, MYLAN LABORATORIES LIMITED, LAUREL PHARMA LABS — together account for 100% of total trade value on this route. The average shipment value of $174.4K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as fenofibrate tab 145mg batch no. ffc23088, ffc23089,ffc23090,ffc23091,ffc23092 mfg dt.12.2023 exp dt.12.2024kgs and fenofibrate tab 145mg b.no-batch no.ffc24046,ffc24047,ffc24048,ffc24049,ffc24050 mfg dt-05.24exp dt-05.25, suggesting that buyers in Hungary tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, MYLAN HUNGARY KFT is the largest importer with 18 shipments worth $4.2M USD — representing 100% of all fenofibrate imports from India on this route.
Route Statistics
- Trade Volume
- $4.2M
- Avg. Shipment
- $174.4K
- Suppliers
- 3
- Buyers
- 3
- Transit (Sea)
- ~22 days
- Annual Growth
- +21.1%
Related Analysis
Other Fenofibrate Routes
Unlock the Full India to Hungary Fenofibrate Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 24 shipments on this route.
Frequently Asked Questions — India to Hungary Fenofibrate Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Fenofibrate to Hungary?
The leading Indian exporters of Fenofibrate to Hungary are ABBOTT HEALTHCARE PRIVATE LIMITED, MYLAN LABORATORIES LIMITED, LAUREL PHARMA LABS. ABBOTT HEALTHCARE PRIVATE LIMITED holds the largest market share at approximately 100% of total trade value on this route.
Q What is the total value of Fenofibrate exports from India to Hungary?
India exports Fenofibrate to Hungary worth approximately $4.2M USD across 24 recorded shipments. The average value per shipment is $174.4K USD.
Q Which ports does India use to ship Fenofibrate to Hungary?
The most active port of origin is CHAWAPAYAL ICD (INCPR6) with 8 shipments. Indian exporters primarily use sea freight for this route, with 80% of shipments going by sea and 26% by air.
Q How long does shipping take from India to Hungary for Fenofibrate?
The average transit time for Fenofibrate shipments from India to Hungary is approximately 22 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to Hungary Fenofibrate trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 21.1% with demand growth tracking at 19.8%. The route is ranked #17 among India's top Fenofibrate export destinations globally.
Q How many suppliers are active on the India to Hungary Fenofibrate route?
There are currently 3 active Indian suppliers exporting Fenofibrate to Hungary. The market is moderately concentrated with ABBOTT HEALTHCARE PRIVATE LIMITED accounting for 100% of total shipment value.
Q Who are the main importers of Fenofibrate from India in Hungary?
The leading importers of Indian Fenofibrate in Hungary include MYLAN HUNGARY KFT, ANNA ASZALOS MYLAN HUNGARY KFT H, MYLAN HUNGARY KFT KOMAROM PLANT MYLAN U. MYLAN HUNGARY KFT is the largest buyer with 18 shipments worth $4.2M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Hungary export trade corridor identified from Indian Customs (DGFT) records for Fenofibrate.
- 2.Supplier/Buyer Matching: 3 Indian exporters and 3 importers in Hungary matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 24 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
24 Verified Shipments
3 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists